FLDP-8
FLDP-8 is a curcuminoid analogues, has potent anti-cancer effects. FLDP-8 can induce cell death with an IC50 value of 4 μM in LN-18 cells.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 861968-02-7
- Fòrmula: C22H23NO5
- Peso molecular:381.42
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
IC50: 4 μM (LN-18 cells)[1]
FLDP-8 (0-40 μM, 24 h) induces cell death process with an IC50 value of 4 μM in a concentration-dependent manner in LN-18 cells, which involves oxidative stress[1].
FLDP-8 (1.25 μM, 2.5 μM, 24 h) induces significant S-phase cell cycle arrest[1].
FLDP-8 (2.5 μM, 5 μM, 24 h) exhibits anti-cancer effects with anti-proliferative, anti-migratory and high potency of BBB permeable properties in Glioblastoma multiforme (GBM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LN-18 cells and HBEC‑5i cells
-
Concentration:0.625 μM -20 μM (LN‑18 cells) 1.25 μM - 40 μM (HBEC‑5i cells)
-
Incubation Time:24 h
-
Result:Induced cytotoxicity on LN‑18 cells and HBEC‑5i cells.
-
Cell Line:LN-18 cells
-
Concentration:1.25 μM, 2.5 μM
-
Incubation Time:24 h
-
Result:Induced arrest in S phase in a concentration-dependent manner.
-
Cell Line:LN-18 cells
-
Concentration:2.5 μM, 5 μM
-
Incubation Time:24 h
-
Result:Inhibited the invasion of LN‑18 cells.
-
Cell Line:LN-18 cells
-
Concentration:2.5 μM, 5 μM
-
Incubation Time:24 h
-
Result:Showed a high potential in inhibiting the migration of LN-18 cells.
Chemical Information
-
No. CAS 861968-02-7
-
Peso molecular 381.42
-
Fòrmula C22H23NO5
-
SMILES
O=C1/C(CN(C)C/C1=C\C2=CC=C(O)C(OC)=C2)=C/C3=CC=C(O)C(OC)=C3
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)